Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neoleukin Therapeutics, Inc. | Former Chief Medical Officer | Common Stock | 37.3K | $25.9K | $0.69 | Apr 3, 2023 | Direct |
Neoleukin Therapeutics, Inc. | Former Chief Medical Officer | Restricted Stock Units | 0 | Mar 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NLTX | Neoleukin Therapeutics, Inc. | Mar 31, 2023 | 3 | -$2.61K | 4 | Apr 4, 2023 | Former Chief Medical Officer |
NLTX | Neoleukin Therapeutics, Inc. | Feb 1, 2023 | 3 | -$8.59K | 4 | Feb 3, 2023 | Chief Medical Officer |
NLTX | Neoleukin Therapeutics, Inc. | Aug 2, 2022 | 1 | $0 | 4 | Aug 4, 2022 | Chief Medical Officer |
NLTX | Neoleukin Therapeutics, Inc. | Apr 30, 2022 | 3 | -$6.75K | 4 | May 3, 2022 | Chief Medical Officer |
NLTX | Neoleukin Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Medical Officer |
NLTX | Neoleukin Therapeutics, Inc. | Aug 3, 2021 | 1 | $0 | 4 | Aug 5, 2021 | Chief Medical Officer |